Abstract
BackgroundAssessing damage accrual (DA) in patients with systemic lupus erythematosus (SLE) is complex but mandatory. Damage might be caused by the disease itself, comorbidities, and/or its pharmacological treatment or both....
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
